Amy Ford
Impact in
- Molecular Biology top 5%
- Fibroblast Growth Factor Research
- Kruppel-like factors research
- Epigenetics and DNA Methylation
- Metabolism, Diabetes, and Cancer
-
- Lipid metabolism and disorders
Papers in
- Oncology 3
- Lung Cancer Research Studies 1
-
- Kruppel-like factors research 2
- Fibroblast Growth Factor Research 2
- Epigenetics and DNA Methylation 1
- Co-authors
- S. Richard Jaskunas (2 shared papers)Victor J. Wroblewski (2 shared papers)Radmila Micanovic (2 shared papers)Alexei Kharitonenkov (2 shared papers)Anja Köester (2 shared papers)Julie S. Moyers (1 shared paper)Rebecca A. Owens (1 shared paper)Joseph T. Brozinick (1 shared paper)
- Journals
- Gynecologic Oncology (1 paper)Journal of Clinical Investigation (1 paper)Clinical Medicine (1 paper)European Journal of Cancer (1 paper)Endocrinology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Amy Ford
7 papers receiving 2.3k citations
Amy Ford's Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 1.5k
- Cardiology and Cardiovascular Medicine 377
- Endocrinology, Diabetes and Metabolism 260
- Physiology 382
- Endocrine and Autonomic Systems 82
Countries citing papers authored by Amy Ford
This map shows the geographic impact of Amy Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ford more than expected).
Fields of papers citing papers by Amy Ford
This network shows the impact of papers produced by Amy Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ford. The network helps show where Amy Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | FGF-21 as a novel metabolic regulator Hit paper breakdown → | 2005 | 1764 |
| 2 | 2005 | 365 | |
| 3 | 2013 | 146 | |
| 4 | 2011 | 72 | |
| 5 | 2004 | 29 | |
| 6 | 2014 | 5 | |
| 7 | 2024 | 3 |
About Amy Ford
Amy Ford is a scholar working on Oncology, Molecular Biology, Dermatology, Cardiology and Cardiovascular Medicine and Clinical Biochemistry, having authored 7 papers that have together received 2.4k indexed citations. Recurring topics across this work include Kruppel-like factors research (2 papers), Fibroblast Growth Factor Research (2 papers), Chemotherapy-related skin toxicity (1 paper), Epigenetics and DNA Methylation (1 paper), Lung Cancer Research Studies (1 paper), Genetic Syndromes and Imprinting (1 paper), Lipid metabolism and disorders (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Molecular Biology (1.5k citations), Cardiology and Cardiovascular Medicine (377 citations), Endocrinology, Diabetes and Metabolism (260 citations), Physiology (382 citations) and Endocrine and Autonomic Systems (82 citations). Amy Ford has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include S. Richard Jaskunas, Victor J. Wroblewski, Radmila Micanovic, Alexei Kharitonenkov, Anja Köester, Julie S. Moyers, Rebecca A. Owens, Joseph T. Brozinick, LI De-shan and Eric D. Hawkins. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Investigation, Clinical Medicine, European Journal of Cancer and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.